0 0
Read Time:2 Minute, 23 Second

 

February 16, 2024

The Yogi Adityanath-led government in Uttar Pradesh has unveiled an ambitious plan to eliminate filariasis, commonly known as elephantiasis, from the state by 2026, aligning its efforts with the Central government’s target of achieving nationwide eradication by 2027. This initiative, setting a pace well ahead of the global target of 2030, underscores the government’s unwavering commitment to combatting debilitating diseases and improving public health.

To achieve this monumental goal, the state government has initiated a comprehensive door-to-door administration of anti-filarial medications across several districts as part of the Mass Drug Administration (MDA) campaign. This initiative aims to ensure that every household in the state is reached in the battle against filariasis.

Effective monitoring by Chief Minister Yogi Adityanath has already yielded promising results, with approximately 20 percent of the population having received medication within the first four days of the campaign. The initiative is scheduled to run until February 28, as per an official statement.

Simultaneously, individuals identified as patients receive specialized training and support through the Morbidity Management and Disability Prevention (MMDP) program. This initiative provides tailored treatment regimens and exercises to aid in the continuous recovery of individuals with mild infections.

Chief Minister Adityanath has emphasized the importance of not only distributing medication but also educating the populace about the disease, highlighting the critical role of awareness in achieving the campaign’s objectives.

Since assuming office in 2017, Chief Minister Adityanath has spearheaded efforts to combat various serious diseases prevalent in the state. His proactive stance has led to significant progress, with Uttar Pradesh now free from many diseases that once afflicted its population.

Communities across various districts have displayed a keen interest in learning about filariasis and the potential side effects of the medication. Health teams are actively engaged in reassuring the populace about the safety of the anti-filarial medication, despite occasional symptoms like headache, body pain, fever, vomiting, rashes, and itching, which typically subside on their own.

While initial hesitancy towards medication has been observed in some areas, proactive engagement by health teams has resulted in increased acceptance and participation among the populace. State Program Officer for Filariasis, Ramesh Singh Thakur, revealed that the MDA campaign aims to administer medication to over 3.6 crore individuals across the state.

Filariasis, a chronic and incurable disease, severely impacts the lymphatic system, with symptoms often manifesting years after contraction. Concealing symptoms can exacerbate the condition, making timely intervention imperative.

Currently, 51 districts in the state are grappling with filariasis, with the ongoing campaign operational in 17 of these districts. The government’s progressive schemes, including Ayushman Arogya Mandir and government health centers, aim to provide timely assistance and benefits to those affected by filariasis.

The aggressive campaign against filariasis reflects the Uttar Pradesh government’s steadfast resolve to prioritize public health and ensure the well-being of its citizens.

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %